A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants

NCT07220551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: UCB0022

Sponsor

UCB Biopharma SRL